03.12.24 -- A Data-Derived Approach For Selecting Criticality Levels In FMECAs

Despite the benefits of B/F/S over glass, some pharmaceutical companies refuse to make the switch. Explore how an investment in B/F/S may yield incredible long-term savings.

If the lyophilization process is applied to a single droplet of liquid, it creates a lyo ‘bead’ rather than a lyo 'cake.' Discover the potential of lyobeads and why they are an excellent alternative.

Finding the right mixing equipment isn’t as simple as selecting an item from a menu. Here is what you should consider when choosing pharmaceutical mixing equipment and vendors for a facility.

Laser-based headspace analysis is a nondestructive and rapid method for testing container closure integrity. We demonstrate that headspace analysis is equally as sensitive as helium leak rate testing.

What does the BATH-O-CARD acronym represent, and how can it help you during your aqueous cleaning process?

Explore what remote regulatory assessments (RRAs) are and how updated guidance on these examinations could help clarify the consequences of noncompliance.

Facility monitoring software with OPC UA client/server functionality makes great business sense. Learn how monitoring leads to reduced waste, improved yield, higher quality, and increased profits.

Learn how to overcome the hurdles associated with traditional data management approaches and discover the key to reducing the risk of drug shortages in pharmaceutical manufacturing.

The drug development industry recognizes the importance of predictive validity, but Jack Scannell, the author of Eroom’s law, and a team of experts argue it is far more crucial than most believe it is.

Find solutions to five key challenges of quality assurance and information to help you identify which product inspection products can best support your application.

The pharmaceutical industry is shifting toward decentralized manufacturing models to improve patient access to life-changing therapies.

It is important to consider several factors in the overall development approach during the early phases in order to de-risk the late-phase development of your biologic drug product.

Without proper handling and packaging, the efficacy of probiotics can be compromised at any point in the packaging, storage, and transportation process, impacting shelf life and effectiveness.